Celyad Oncology Pink Sheet Forecast - Simple Exponential Smoothing
| CLYYF Stock | USD 0.15 0.03 16.67% |
The Simple Exponential Smoothing forecasted value of Celyad Oncology SA on the next trading day is expected to be 0.15 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.26. Celyad Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Celyad Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
Celyad |
Celyad Oncology Simple Exponential Smoothing Price Forecast For the 28th of December
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Celyad Oncology SA on the next trading day is expected to be 0.15 with a mean absolute deviation of 0, mean absolute percentage error of 0.0008, and the sum of the absolute errors of 0.26.Please note that although there have been many attempts to predict Celyad Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Celyad Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Celyad Oncology Pink Sheet Forecast Pattern
| Backtest Celyad Oncology | Celyad Oncology Price Prediction | Buy or Sell Advice |
Celyad Oncology Forecasted Value
In the context of forecasting Celyad Oncology's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Celyad Oncology's downside and upside margins for the forecasting period are 0 and 6.89, respectively. We have considered Celyad Oncology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Celyad Oncology pink sheet data series using in forecasting. Note that when a statistical model is used to represent Celyad Oncology pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.086 |
| Bias | Arithmetic mean of the errors | 0.0043 |
| MAD | Mean absolute deviation | 0.0043 |
| MAPE | Mean absolute percentage error | 0.0227 |
| SAE | Sum of the absolute errors | 0.26 |
Predictive Modules for Celyad Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Celyad Oncology SA. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celyad Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Celyad Oncology
For every potential investor in Celyad, whether a beginner or expert, Celyad Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Celyad Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Celyad. Basic forecasting techniques help filter out the noise by identifying Celyad Oncology's price trends.View Celyad Oncology Related Equities
| Risk & Return | Correlation |
Celyad Oncology SA Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Celyad Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Celyad Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Celyad Oncology Market Strength Events
Market strength indicators help investors to evaluate how Celyad Oncology pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Celyad Oncology shares will generate the highest return on investment. By undertsting and applying Celyad Oncology pink sheet market strength indicators, traders can identify Celyad Oncology SA entry and exit signals to maximize returns.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.83 | |||
| Day Median Price | 0.15 | |||
| Day Typical Price | 0.15 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.03) |
Celyad Oncology Risk Indicators
The analysis of Celyad Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Celyad Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting celyad pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.29 | |||
| Standard Deviation | 6.74 | |||
| Variance | 45.44 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Celyad Pink Sheet
Celyad Oncology financial ratios help investors to determine whether Celyad Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Celyad with respect to the benefits of owning Celyad Oncology security.